Who we are
Shenzhen Aivd Biotechnology Co. , LTD., ISO 13485 and ISO 9001 certified , is a China high-tech enterprise specialized in supplying complete solution for IVD industry globally, our core team members have rich experience in products R&D, production and registration.
AIVD Biotech offers professional, high-quality service for our clients by providing complete solutions from raw materials to finished products, products and services applicable to diverse application scenarios and platforms!
Ever since the foundation, AIVD has successfully delivered a number of first-of-its-kind diagnostic reagent products in China, solved numerous product process and production problems for our clients, furthermore, AIVD has partially realized the localization substitution of imported raw materials.
AIVD has working area of 5000 square meters, of which 3000 square meters of R&D and 2000 square meters production. More than 100 employees of which 70% are R&D members composed of doctors, masters and bachelors. AIVD has 2 technology centers: diagnostic raw material technical center and diagnostic reagents technical center. The raw material technology center includes the R&D and production of recombinant antigens, antibodies (including nanoantibodies), enzyme and molecular diagnostics. The diagnostic reagent technology center includes ELISA, Colloidal gold and Fluorescence based Lateral Flow, Chemiluminescence, Immunoturbidimetric and molecular diagnostic platform.
For various R&D and production pain points faced by IVD industry, such as high cost of raw materials, long production development cycle, low product clinical data coincidence, unstable production, etc, AIVD provides complete technical solutions including custom development, mass production and OEM service from raw materials to finished products, optimization from products to manufacturing technique, etc.
AIVD R&D centers
- In-vitro Diagnostics Raw Material Technology R&D Center. The center includes genetic, protein and enzyme engineering platforms;
- In-vitro Diagnostics Assay Development Center. We assist our clients in developing a point of care lateral flow, including colloidal gold, fluorescent signal, and paramagnetic labels – based assays, ELISA, chemiluminescent immunoassays and molecular diagnostic assays.
- New Products R&D center. The center primarily focuses on research in the biomedical field, includes Liquid Biopsy and Microfluidics platforms.
AIVD Milestones
AIVD Founded and three technology platforms of genetic engineering, protein engineering and antibody engineering were set up.
Established colloidal gold chromatography and enzyme-linked immunoassay technology platform
Establishment of monoclonal antibody preparation platform
Established fluorescence POCT and molecular diagnostic technology platform, certified as “National High-tech Enterprise” and “Shenzhen High-tech Enterprise”.
Established chemiluminescence technology platform, established mammalian cell expression platform
Established nano-antibody and recombinant antibody platform
Completed Series A financing
Obtained ISO13485 quality management system certification
